Received: 26 June 2019
Accepted: 14 April 2020
First Online: 21 April 2020
Change Date: 4 May 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: We provided the patient with detailed information about all anti-VEGF drugs before treatment. The patient chose aflibercept, medication of off label use, and signed the consent form after fully understanding.
: Written informed consent was obtained from the patient for publication of this case report and accompanying images.
: The authors declare that they have no competing interests.